SIRT3 and metabolic disease: 3-TYP, a selective SIRT3 inhibitor, reversed AEDC effect on autophagy, indicating that AEDC inhibited NLRP3 inflammasome activation to ameliorate inflammation-related metabolic disorders by promoting autophagy via SIRT3.